Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Patient perceptions, motivations and barriers to treatment adherence in hypertension: results of a questionnaire-based survey in five European countries

M. Burnier, M. Azizi, J. Magne, A. Prejbisz, V. Cunha, P. Gupta, J. Vaclavik, J. Versmissen, V. Cornelissen, M. Dorobantu, G. Desideri, A. Persu, SE. Kjeldsen, R. Kreutz, T. Weber, Working group on Lifestyle, Cardiovascular Pharmacotherapy and...

. 2025 ; 34 (1) : 2513434. [pub] 20250606

Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc25015077

AIMS: To assess perceptions, motivations and barriers to treatment adherence depending on emotional, lifestyle, medical and non-adherence risk profiles in hypertensive patients. METHODS AND RESULTS: Cross-sectional data were obtained using an online anonymous survey. Four distinct global risk scores (medical, lifestyle, emotional and quality of life (QoL) and non-adherence risk scores) were calculated based on the responses to specific groups of questions. A total of 2615 treated hypertensive patients (≥18 years of age) from 5 European countries completed the questionnaire. Mean (SD) age was 69.6 years (5.8); 54% males. Overall, antihypertensive therapy represented a low burden in patients' daily life (2.9/10 in the Likert scale). Perfect self-reported adherence was claimed by 59.8% of participants. Reporting of non-adherence episodes to physicians was low (13% always/often). Participants with a high non-adherence risk score had a greater number of associated diseases (obesity, sleep disturbances, depression and cardiac complications), a higher treatment-associated burden on daily life, a greater stress level and more antihypertensive pills per day (p < 0.001 for all). No correlation was found between the clinical and lifestyle risk scores and the risk of non-adherence. The emotional score correlated significantly with the non-adherence risk score (p < 0.001). Comparing patients with a low/middle risk to those with a high risk of non-adherence, female gender and age >65 years were associated with a lower odd ratio of non-adherence whereas depression, stress, family hardships, negative information on drugs and poor information were associated with higher odds of non-adherence. CONCLUSIONS: This large survey reveals several underestimated issues regarding patients' perspective in hypertension. It highlights the impact of emotions, exposure to family hardships, and stress on the risk of non-adherence. Non-adherence is underreported by patients; hence it remains mostly unrecognised.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015077
003      
CZ-PrNML
005      
20250731090740.0
007      
ta
008      
250708s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/08037051.2025.2513434 $2 doi
035    __
$a (PubMed)40445169
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Burnier, Michel $u Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland $1 https://orcid.org/0000000312838487
245    10
$a Patient perceptions, motivations and barriers to treatment adherence in hypertension: results of a questionnaire-based survey in five European countries / $c M. Burnier, M. Azizi, J. Magne, A. Prejbisz, V. Cunha, P. Gupta, J. Vaclavik, J. Versmissen, V. Cornelissen, M. Dorobantu, G. Desideri, A. Persu, SE. Kjeldsen, R. Kreutz, T. Weber, Working group on Lifestyle, Cardiovascular Pharmacotherapy and Adherence of the European Society of Hypertension
520    9_
$a AIMS: To assess perceptions, motivations and barriers to treatment adherence depending on emotional, lifestyle, medical and non-adherence risk profiles in hypertensive patients. METHODS AND RESULTS: Cross-sectional data were obtained using an online anonymous survey. Four distinct global risk scores (medical, lifestyle, emotional and quality of life (QoL) and non-adherence risk scores) were calculated based on the responses to specific groups of questions. A total of 2615 treated hypertensive patients (≥18 years of age) from 5 European countries completed the questionnaire. Mean (SD) age was 69.6 years (5.8); 54% males. Overall, antihypertensive therapy represented a low burden in patients' daily life (2.9/10 in the Likert scale). Perfect self-reported adherence was claimed by 59.8% of participants. Reporting of non-adherence episodes to physicians was low (13% always/often). Participants with a high non-adherence risk score had a greater number of associated diseases (obesity, sleep disturbances, depression and cardiac complications), a higher treatment-associated burden on daily life, a greater stress level and more antihypertensive pills per day (p < 0.001 for all). No correlation was found between the clinical and lifestyle risk scores and the risk of non-adherence. The emotional score correlated significantly with the non-adherence risk score (p < 0.001). Comparing patients with a low/middle risk to those with a high risk of non-adherence, female gender and age >65 years were associated with a lower odd ratio of non-adherence whereas depression, stress, family hardships, negative information on drugs and poor information were associated with higher odds of non-adherence. CONCLUSIONS: This large survey reveals several underestimated issues regarding patients' perspective in hypertension. It highlights the impact of emotions, exposure to family hardships, and stress on the risk of non-adherence. Non-adherence is underreported by patients; hence it remains mostly unrecognised.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a senioři $7 D000368
650    12
$a hypertenze $x farmakoterapie $x psychologie $x epidemiologie $7 D006973
650    _2
$a lidé středního věku $7 D008875
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a průřezové studie $7 D003430
650    12
$a antihypertenziva $x terapeutické užití $7 D000959
650    12
$a motivace $7 D009042
650    _2
$a kvalita života $7 D011788
650    12
$a adherence k farmakoterapii $x psychologie $7 D055118
650    _2
$a životní styl $7 D008019
650    _2
$a senioři nad 80 let $7 D000369
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Azizi, Michel $u INSERM CIC1418, Hypertension Department, Hôpital Européen Georges-Pompidou, Université de Paris Cité, Paris, France $1 https://orcid.org/0000000305978318
700    1_
$a Magne, Julien $u Faculty of Medicine, University of Limoges, Limoges, France $1 https://orcid.org/000000015290531X
700    1_
$a Prejbisz, Aleksander $u Department of Epidemiology, Cardiovascular Prevention and Health Promotion, National Institute of Cardiology, Warsaw, Poland $1 https://orcid.org/0000000170850244
700    1_
$a Cunha, Vitoria $u Hospital Garcia de Orta, Almada, Portugal $1 https://orcid.org/0000000292388668
700    1_
$a Gupta, Pankaj $u Department of Cardiovascular Sciences and NIHR Biomedical Research Centre Leicester, University of Leicester, Leicester, UK $1 https://orcid.org/0000000194816067
700    1_
$a Vaclavik, Jan $u Faculty of Medicine, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000178470967 $7 xx0169228
700    1_
$a Versmissen, Jorie $u Erasmus MC University Medical Center, Rotterdam, The Netherlands $1 https://orcid.org/0000000306747765
700    1_
$a Cornelissen, Véronique $u Department of Rehabilitation Sciences, University of Leuven, Leuven, Belgium $1 https://orcid.org/0000000205784954
700    1_
$a Dorobantu, Maria $u Cardiology Department, Emergency Hospital of Bucharest, Bucharest, Romania $1 https://orcid.org/0000000319405262
700    1_
$a Desideri, Giovambattista $u Department of Life, Health, and Environmental Sciences, Senior International Health Association, University of L'Aquila, L'Aquila, Italy $1 https://orcid.org/0000000201451271
700    1_
$a Persu, Alexandre $u Department of Cardiology, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium $1 https://orcid.org/0000000240079695
700    1_
$a Kjeldsen, Sverre E $u Department of Cardiology and Nephrology, University of Oslo Hospital, Institute for Clinical Medicine, Ulleval Hospital, Oslo, Norway $1 https://orcid.org/0000000323890272
700    1_
$a Kreutz, Reinhold $u Institute of Clinical Pharmacology and Toxicology, Charité - University Medicine Berlin, Berlin, Germany $1 https://orcid.org/000000024818211X
700    1_
$a Weber, Thomas $u Cardiology Department, Klinikum Wels-Grieskirchen, Wels, Austria $1 https://orcid.org/0000000306170417
710    2_
$a Working group on Lifestyle, Cardiovascular Pharmacotherapy and Adherence of the European Society of Hypertension
773    0_
$w MED00000810 $t Blood pressure $x 1651-1999 $g Roč. 34, č. 1 (2025), s. 2513434
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40445169 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731090735 $b ABA008
999    __
$a ok $b bmc $g 2366143 $s 1252202
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 34 $c 1 $d 2513434 $e 20250606 $i 1651-1999 $m Blood pressure $n Blood Press $x MED00000810
LZP    __
$a Pubmed-20250708

Find record

Citation metrics

Archiving options